INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

73,160 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
MF
Mottola FrankSVP, Chief Tech. Ops. Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
14.0K sh
Nov 2, 2026
Page 133 of 1829
← PrevNext →
Nov 4, 2026
traded Nov 2, 2026
+2d
SEC Form 4

Evidence

12
GG
Gemayel GeorgesDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
9,305 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
BC
Barlow CarroleeDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
12.4K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
HM
Hudson Frederick M.Director
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
12.4K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
HM
Hudson Frederick M.Director
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
7,365 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
BP
Bhatt Padmanabh P.Sr. VP of IP, CSO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
100.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
BC
Barlow CarroleeDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
6,293 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
MF
Mottola FrankSVP, Chief Tech. Ops. Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
22.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
GG
Gemayel GeorgesDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
7,365 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
BP
Bhatt Padmanabh P.Sr. VP of IP, CSO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
20.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
KA
Khattar Jack A.Director, President, CEO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
322.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
BC
Barlow CarroleeDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
10.2K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
KA
Khattar Jack A.Director, President, CEO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
280.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
MA
Merriman Dwight ADirector
MDBMongoDB, Inc.
Open-market sale · 10b5-1 plan
SELL$1.38M
3,963 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
CP
Coghlan John PhilipDirector
LIFLife360, Inc.
Open-market sale · 10b5-1 plan
SELL$83K
1,841 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
14.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
DC
Dec Timothy CSenior Vice-President & CFO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
17.5K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
MF
Mottola FrankSVP, Chief Tech. Ops. Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
3,350 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
LB
Levine Kyle BEVP Corp Pub Aff & Chf Leg Off
ALKALASKA AIR GROUP, INC.
Tax withholding
F$73K
1,912 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
KA
Khattar Jack A.Director, President, CEO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
250.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
HM
Hudson Frederick M.Director
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
6,293 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
BP
Bhatt Padmanabh P.Sr. VP of IP, CSO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
2,500 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
TD
Tsao DavidDirector, Chief Technology Officer
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$23K
208 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
FL
Flavin LisaSenior VP & CCO
EMREMERSON ELECTRIC CO
Tax withholding
F$125K
750 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

12
SS
Singh SumitDirector, Chief Executive Officer
CHWYChewy, Inc.
Open-market sale · 10b5-1 plan
SELL$492K
23.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
MF
Mottola FrankSVP, Chief Tech. Ops. Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
3,375 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
BC
Barlow CarroleeDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
9,305 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
MF
Mottola FrankSVP, Chief Tech. Ops. Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
30.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
BP
Bhatt Padmanabh P.Sr. VP of IP, CSO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
13.5K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
MA
Merriman Dwight ADirector
MDBMongoDB, Inc.
Open-market sale · 10b5-1 plan
SELL$1.70M
4,846 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
BC
Barlow CarroleeDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
4,977 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
MF
Mottola FrankSVP, Chief Tech. Ops. Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
17.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
MF
Mottola FrankSVP, Chief Tech. Ops. Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
18.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
BC
Barlow CarroleeDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
6,847 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
BP
Bhatt Padmanabh P.Sr. VP of IP, CSO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
15.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$3.48M
13.8K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
DC
Dec Timothy CSenior Vice-President & CFO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
6,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
HA
Hovnanian Alexander A.President
HOVHOVNANIAN ENTERPRISES INC
Tax withholding
F$81K
770 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
HM
Hudson Frederick M.Director
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
60.4K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
BP
Bhatt Padmanabh P.Sr. VP of IP, CSO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
3,500 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence